title: Current controversies in prenatal diagnosis 3: is there still a value in a nuchal translucency screening ultrasound in conjunction with maternal plasma non-invasive cell-free DNA testing?
authors.affiliation: Department of Obstetrics and Gynaecology, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada.
authors.forename: R Douglas
authors.initials: RD
authors.lastname: Wilson
authors.affiliation: Division of Women's Health, King's College London, London, UK.
authors.forename: Liona C
authors.initials: LC
authors.lastname: Poon
authors.affiliation: Perinatal Diagnostic Center, Inova Alexandria Hospital, Alexandria, VA, USA.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Ghidini
mesh_terms: D000782:Aneuploidy; D015415:Biomarkers / Q000097:blood; D000013:Congenital Abnormalities / Q000175:diagnosis* / Q000235:genetics; D004247:DNA / Q000097:blood; D034462:Dissent and Disputes; D005260:Female; D006801:Humans; D062145:Maternal Serum Screening Tests; D048208:Nuchal Translucency Measurement; D011247:Pregnancy
chemical_list: D015415:Biomarkers; D004247:DNA